GLP-1 receptor agonists mimic incretin biology. Landmark programmes (e.g. STEP for semaglutide) are the right citation starting points. Research catalogue items are not licensed medicines.
EXPLAINER
Class explainer — GLP-1 receptor agonists
Research & laboratory use only
This article supports qualified researchers. It is not medical advice and must not be used to plan human or veterinary administration.
Primary literature
- Once-Weekly Semaglutide in Adults with Overweight or ObesityNew England Journal of Medicine (2021)
- A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight ManagementNew England Journal of Medicine (2015)
Related guides
Research updates
New batches and their COAs, plus documentation and handling guides. No hype, unsubscribe any time.